Mascoma Wealth Management’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $35.6K | Hold |
187
| – | – | 0.01% | 210 |
|
|
2026
Q1 | $31.6K | Hold |
187
| – | – | 0.01% | 224 |
|
|
2025
Q4 | $31.6K | Hold |
187
| – | – | 0.01% | 219 |
|
|
2025
Q3 | $27K | Sell |
187
-134
| -42% | -$18.3K | 0.01% | 239 |
|
|
2025
Q2 | $40.6K | Hold |
321
| – | – | 0.01% | 204 |
|
|
2025
Q1 | $41K | Hold |
321
| – | – | 0.01% | 201 |
|
|
2024
Q4 | $42.4K | Hold |
321
| – | – | 0.01% | 212 |
|
|
2024
Q3 | $46.7K | Sell |
321
-11
| -3% | -$1.59K | 0.01% | 199 |
|
|
2024
Q2 | $45.5K | Sell |
332
-20
| -6% | -$2.67K | 0.01% | 203 |
|
|
2024
Q1 | $48.3K | Sell |
352
-151
| -30% | -$20.6K | 0.01% | 185 |
|
|
2023
Q4 | $68.3K | Sell |
503
-192
| -28% | -$23.4K | 0.02% | 160 |
|
|
2023
Q3 | $85.1K | Hold |
695
| – | – | 0.03% | 148 |
|
|
2023
Q2 | $88.6K | Sell |
695
-18
| -3% | -$2.34K | 0.03% | 146 |
|
|
2023
Q1 | $93.1K | Sell |
713
-60
| -8% | -$7.85K | 0.03% | 170 |
|
|
2022
Q4 | $102K | Sell |
773
-15
| -2% | -$1.94K | 0.03% | 162 |
|
|
2022
Q3 | $92K | Sell |
788
-8
| -1% | -$993 | 0.03% | 170 |
|
|
2022
Q2 | $94K | Sell |
796
-331
| -29% | -$39.3K | 0.03% | 175 |
|
|
2022
Q1 | $147K | Buy |
1,127
+103
| +10% | +$13.4K | 0.05% | 143 |
|
|
2021
Q4 | $156K | Buy |
1,024
+243
| +31% | +$37.6K | 0.05% | 121 |
|
|
2021
Q3 | $126K | Buy |
+781
| New | +$131K | 0.05% | 134 |
|
|
2021
Q2 | – | Sell |
-302
| Closed | -$45K | – | 260 |
|
|
2021
Q1 | $45K | Buy |
+302
| New | +$48K | 0.02% | 218 |
|
|
2019
Q3 | – | Sell |
-738
| Closed | -$81K | – | 204 |
|
|
2019
Q2 | $81K | Sell |
738
-123
| -14% | -$13.1K | 0.05% | 126 |
|
|
2019
Q1 | $96K | Sell |
861
-24
| -3% | -$2.63K | 0.06% | 108 |
|
|
2018
Q4 | $85K | Sell |
885
-492
| -36% | -$52.2K | 0.06% | 112 |
|
|
2018
Q3 | $168K | Hold |
1,377
| – | – | 0.11% | 85 |
|
|
2018
Q2 | $151K | Hold |
1,377
| – | – | 0.11% | 83 |
|
|
2018
Q1 | $147K | Sell |
1,377
-390
| -22% | -$43.2K | 0.1% | 85 |
|
|
2017
Q4 | $198K | Sell |
1,767
-420
| -19% | -$44.9K | 0.12% | 71 |
|
|
2017
Q3 | $243K | Hold |
2,187
| – | – | 0.16% | 65 |
|
|
2017
Q2 | $226K | Hold |
2,187
| – | – | 0.15% | 66 |
|
|
2017
Q1 | $214K | Sell |
2,187
-150
| -6% | -$14.4K | 0.15% | 57 |
|
|
2016
Q4 | $207K | Buy |
+2,337
| New | +$213K | 0.15% | 60 |
|
Other funds holding IBB
CB
Mascoma Wealth Management's IBB Position: Q2 2026 in Review
Mascoma Wealth Management held its iShares Biotechnology ETF (IBB) position steady in Q2 2026 at 187 shares worth $35.6K. The position accounts for 0.01% of the portfolio, ranked #210.
Mascoma Wealth Management first reported a position in IBB in Q4 2016 and has held it in 32 quarters since. The position peaked at $243K in Q3 2017. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.
- Mascoma Wealth Management held 187 shares of iShares Biotechnology ETF worth $35.6K as of Q2 2026.
- Mascoma Wealth Management left its iShares Biotechnology ETF share count unchanged in Q2 2026.
- iShares Biotechnology ETF made up 0.01% of Mascoma Wealth Management's portfolio in Q2 2026, its #210 holding.
- Mascoma Wealth Management first reported a position in iShares Biotechnology ETF in Q4 2016 and has held it in 32 quarters since.
- Mascoma Wealth Management's iShares Biotechnology ETF position peaked at $243K in Q3 2017.
- 954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.
Based on Mascoma Wealth Management's 13F filing for Q2 2026, filed 24 Jul 2026.